Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

US Patent 11884665 · Granted Jan 30, 2024

Estimated economic value: $78,082,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolotriazine compounds as tam inhibitors2025
Pyrrolotriazine compounds as tam inhibitors2025
Quinoline compounds as inhibitors of KRAS2025
Hetero-bicyclic inhibitors of KRAS2025
Imidazole and triazole KRAS inhibitors2024
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy2024
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy2024
Hetero-tricyclic compounds as inhibitors of KRAS2024
Pyrazoloquinoline KRAS inhibitors2024
Fused pyrazine derivatives as A2A / A2B inhibitors2024
Vinyl imidazole compounds as inhibitors of KRAS2024
Bicyclic amines as CDK2 inhibitors2024